Eli Lilly’s shares have surged 750 per cent over five years. Novo Nordisk’s are up about 360 per cent in the same period.

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.

Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...

Men, baby boomers, and postgraduate-degree holders were among those most likely to say they wouldn’t choose medication over ...

The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing ...

With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management ...

WHAT TO KNOW ABOUT GLP-1 SHORTAGES — It’s been a busy week in the diabetes and weight-loss drug world as Eli Lilly renews its push to shut down the compounding of its tirzepatide products and the ...

Spinach, green tea, apples, celery, asparagus, coffee and berries are all good examples of foods high in polyphenols - which ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...

When it came to deciding what kinds of foods Vital Pursuit would sell, the team turned to another Nestlé brand, Life Cuisine, for inspiration. Life Cuisine was rolled out in 2020 as a sibling brand to ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...